4D Molecular Therapeutics shares are trading lower after the company announced the price of an upsized public offering of 6,586,015 shares at $29.50 per share.
Portfolio Pulse from Benzinga Newsdesk
4D Molecular Therapeutics announced the price of an upsized public offering of 6,586,015 shares at $29.50 per share, causing its shares to trade lower.
February 07, 2024 | 4:42 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
4D Molecular Therapeutics' shares are trading lower following the announcement of an upsized public offering of 6,586,015 shares at $29.50 per share.
The announcement of a public offering, especially an upsized one, often leads to a decrease in share price due to the dilution of existing shares. The specific pricing at $29.50 per share and the size of the offering are likely to have contributed to the negative short-term impact on FDMT's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100